MYC and neoplasm: Furthermore, GHRH antagonists were able to modulate molecules such as p53, p21, CD44, c-myc, cyclin D1 and Bax/Bcl2 in xenografted tumor and tumor cells triggering the starting of apoptosis and cell cycle arrest.